Notably, anti-NS1 IgG1 levels are consistently higher in patients with acute or past DHF, whereas anti-NS1 IgG3 responses are more prominent in those with milder dengue fever (DF) [11,68], suggesting distinct roles for these subclasses in shaping disease outcome. The gene discussed is IGHG3; the disease is dengue disease.